Results of past animal studies have indicated the antifertility effects of phthalate esters and additional studies have suggested the potential mutagenic effects at very high doses. A toxicity study in mice has also been conducted in which chronic LD50 values were calculated for a group of phthalate esters. For DEHP, for example, the acute LD50 was 38.35 ml/kg, but after 10 weeks the value fell to 1.37 ml/kg, suggesting that the ester was producing a cumulative toxicity. A more recent study explored the possibility that DEHP might be a cumulative toxic agent even at lower doses in regard to antifertility and mutagenic effects in mice. Preliminary results indicated that antifertility effects occurred with as little as three subcutaneous doses of 1 ml/kg each. Calculations of mutagenic index revealed a dose-dependent effect but no stoichiometric relationship was established.
Introduction
In the United States, concern for potential health threats from the leaching of phthalate esters used as plasticizers in poly(vinyl chloride) items such as blood bags and tubings dates back to a report published in 1967 by Guess et al. (1) . Their studies on blood bags containing ACD solution revealed that the plasticizers, as well as degradation products of the ester, were released to the solution. While the quantity of the released chemicals was extremely small, the question was raised for the safety of these products when administered to ill and debilitated patients. Although notice was taken of this report, neither government nor industry took steps to correct the "contaminated" ACD solution or blood products placed in these PVC bags. Their past history of use and their apparent safety mitigated the need for making changes in the plastic though industry had begun to initiate studies to help improve the PVC formula.
Publication of research by Jaeger and Rubin (2) in 1970, however, resurrected the plastic's safety into a broader domain. These (6) studied the teratogenic effects of eight phthalate esters in rats and noted that all compounds, to various degrees, induced birth abnormalities and fetal deaths. Esters included the following: dimethyl, dimethoxyethyl, diethyl, dibutyl, diisobutyl, butyl carobutoxymethyl, dioctyl and di(2-ethylhexyl) phthalates. Groups of animals were administered the various esters by IP injections on days 5, 10, and 15 of gestation at several dose levels. The most widely used phthalate, di(2-ethylhexyl) phthalate (DEHP), was administered at two dose levels, 5 ml and 10 ml/kg, but fetal abnormalities were noted only at the higher dose level.
Since PVC blood bags generally contain DEHP as the plasticizer, a study was conducted by Lewandowski et al. (7) 12-13 of gestation, and uterine horns and ovaries were exposed surgically to determine the number of corpora lutea, implantations, preimplantation losses, early fetal deaths and viable fetuses.
A second series of experiments was also conducted essentially following the previously described procedure. Groups of 10 male mice were treated with DEHP subcutaneously on days 1, 5 and 10 at the following dose levels: 1 ml/kg, 2 ml/kg, 5 ml/kg and 10 ml/kg. A group of untreated mice was used as control. Each male mouse was mated with a fresh virgin female 24 hr after the treatment, followed by a change of females every fifth day up to 21 days and then every week up to 8 weeks. All pregnant females were sacrificed as previously and the corpora lutea, implantations, preimplantation losses, early fetal deaths and viable fetuses recorded. Table 2 summarizes the number of pregnancies occurring for each dose administered, as well as the number of corpora lutea, implants, preimplantation losses, early fetal deaths and live fetuses. It will be bNo pregnancies in this group. 
Results

Discussion
Previous studies in this laboratory demonstrated that at high doses (IP), the phthalate esters could act as teratogenic and antifertility agents (6) . Results from a dominant lethal assay also suggested that the esters might have mutagenic activity (8) . Since DEHP was found to exert a cumulative toxicity effect in mice, these experiments were undertaken to determine antifertility and mutagenic effects of repeated injection of DEHP in mice at various dose levels.
As suggested in Table 2 , antifertility effects were noted with as little as three subcutaneous doses of 1 ml/kg each. Calculations of mutagenic index (early fetal deaths/total implants per pregnancy x 100) have been listed in Table 3 for the various dose levels (1, 2, 5 and 10 ml/kg) over an eight-week period. Even though a dose-dependent effect is apparent, no stoichiometric relationship-has been established.
Expression of mutagenic index in terms of per pregnancy excludes any possible antifertility effect from DEHP, although the antifertility effects observed in this study may also be a consequence of the mutagenic effects rendering the sperm incapable of fertilizing the ovum or for the fertilized ovum to develop.
In a parallel study not reported here, the effect of lower doses of DEHP on testicular structure and function did not show any changes in histopathological organization or macromolecular contents (nucleic acids and protein) of the tissue, suggesting that increased fetal deaths are not a consequence of testicular atrophy. Alterations in the activity of certain mitochondrial and lysosomal enzymes of testicular tissue were, however, observed after treatment with DEHP to account for the changes in the functional ability of the reproductive system.
It has always been a point of argument in selecting doses of DEHP and/or the route of administration in experimental animals which stimulate conditions close to that of human exposure or which provide predictive toxicologic data. A subcutaneous administration would therefore justify the parenteral administration like IV without any possible direct contact with the organs of concern and would certainly be more practical to assess the toxicity of DEHP than oral route where most of the effects would be due to metabolites rather than DEHP itself. Undoubtedly the doses used in the present study are much higher than would be expected to reach the human system through biomedical devices. However, in view of the marked increase in the chronic toxicity and evident accumulation of DEHP in primates, usage of higher doses of DEHP in such short term studies may help in indicating possible risk of mutagenic effects in human beings exposed to relatively smaller doses over a longer period of time.
Further studies in fertility and mutagenic effects of DEHP and other phthalate esters are continuing and the results will be reported in subsequent publications.
